HLB GLOBAL Co., Ltd.

A003580

KR7003580008

Department Stores

End-of-day quote Korea S.E. Other stock markets 18:00:00 2024-05-30 EDT			5-day change	1st Jan Change
4,750 ^KRW	-1.14%		+7.47%	-5.38%

05-07	HLB GLOBAL Co., Ltd. announced that it has received KRW 5.00000271 billion in funding	CI
04-26	HLB GLOBAL Co., Ltd. announced that it expects to receive KRW 5.00000271 billion in funding	CI

NEXT SCIENCE Co., Ltd. cancelled the acquisition of an additional 6.05% stake in Nanogen Biopharmaceutical Co., Ltd. from Ho Nhan and 1 other individual.

March 28, 2020

NEXT SCIENCE Co.,Ltd. (KOSE:A003580) agreed to acquire an additional 6.05% stake in Nanogen Biopharmaceutical Co., Ltd. from Ho Nhan and 1 other individual for $13 million on March 29, 2019. Under the transaction, NEXT SCIENCE Co.,Ltd. will acquire 4.225 million shares of Nanogen Biopharmaceutical Co., Ltd. at $3.08 per share in cash. Upon completion, NEXT SCIENCE Co.,Ltd. will own 9.77% stake in Nanogen Biopharmaceutical Co., Ltd. The transaction has been resolved by the Board of NEXT SCIENCE Co.,Ltd. and is expected to close on March 29, 2019. NEXT SCIENCE Co., Ltd. (KOSE:A003580) cancelled the acquisition of an additional 6.05% stake in Nanogen Biopharmaceutical Co., Ltd. from Ho Nhan and 1 other individual on March 29, 2020.

Latest news about HLB GLOBAL Co., Ltd.

HLB GLOBAL Co., Ltd. announced that it has received KRW 5.00000271 billion in funding	05-06	CI
HLB GLOBAL Co., Ltd. announced that it expects to receive KRW 5.00000271 billion in funding	04-25	CI
HLB GLOBAL Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
HLB GLOBAL Co., Ltd. announced that it has received KRW 21.4 billion in funding from Korea Investment & Securities Co., Ltd., Emoi Co., Ltd. and other investors	23-04-19	CI
HLB GLOBAL Co., Ltd. announced that it expects to receive KRW 21.4 billion in funding from Korea Investment & Securities Co., Ltd., Emoi Co., Ltd. and other investors	23-04-05	CI
HLB GLOBAL Co., Ltd. completed the acquisition of TI Corporation Co., Ltd. from Tae-in Oh.	23-01-17	CI
HLB GLOBAL Co., Ltd. agreed to acquire TI Corporation Co., Ltd. from Tae-in Oh for KRW25 billion.	22-11-30	CI
HLB GLOBAL Co., Ltd. announced that it expects to receive KRW 14 billion in funding	22-11-30	CI
HLB GLOBAL Co., Ltd. acquired 37.55% stake in Fresico Co., Ltd. from Jinsoo Hwang and 11 others for approximately KRW 20,392 million.	22-09-05	CI
HLB GLOBAL Co., Ltd. announced that it has received KRW 8.208 billion in funding from Share House Gong Myeong	22-09-05	CI
Next Science Completes Share Purchase Plan; Shares Up 3%	22-03-22	MT
Next Science Opens Nearly $4 Million Share Purchase Plan	22-03-03	MT
Sang-jun Lee acquired 19.9% of stake in Dongwon Resource Corporation from NEXT SCIENCE Co., Ltd. for KRW 11.4 billion.	22-03-02	CI
G-treeBNT Co., Ltd. announced that it has received KRW 95.000054256 billion in funding from a group of investors	21-11-15	CI
TELA Bio Receives Exclusive Rights to Sell Next Science Antimicrobial Surgical Wash in US	21-11-01	MT
Next Science Signs Distribution Deal for Antimicrobial Cleaning Product	21-11-01	MT
HLB Therapeutics Co.,Ltd. announced that it expects to receive KRW 95.000054256 billion in funding from a group of investors	21-09-12	CI
Next Science : Revenue Soars 271% in H1; Shares Rise 5%	21-07-21	MT
NEXT SCIENCE Co., Ltd. announced that it has received KRW 24 billion in funding from Korea Bond Investment Advisory Co., Ltd.	21-07-14	CI
NEXT SCIENCE Co., Ltd. announced that it expects to receive KRW 24 billion in funding from Korea Bond Investment Advisory Co., Ltd., and other investors	21-06-22	CI
Next Science : Revises Revenue Guidance for H1 CY2021	21-06-14	MT
Next Science : Antimicrobial Wound Gel Gets Sale Clearance from Australian Drug Regulator	21-05-27	MT
Next Science : Receives FDA Clearance for Surgical Antimicrobial Product; Shares Surge 27%	21-04-25	MT
Immunomic Therapeutics, Inc. announced that it has received $77.72823 million in funding from Sonid Inc., HLB GLOBAL Co., Ltd., HLB Co., Ltd.	21-01-13	CI
REUTERS NEXT-Science must determine company climate targets, say executives	21-01-11	RE

Chart HLB GLOBAL Co., Ltd.

Duration

Period

More charts

Company Profile

HLB Global Co Ltd, formerly Next Science Co Ltd, is a Korea-based company principally is engaged in the manufacture and sale of food and beverage. The Company operates its business through three segments. The Food and Beverage Retail Business segment is engaged in the manufacture and sale of fermented milk, confectionery, jam syrup for ice cream and fermented beverage. The Resource Business segment is engaged in the manufacture and sale of aggregates. The Cosmetics Business segment is engaged in the businesses including cosmetics manufacturing and sale, health functional food sale, among other businesses.

Sector

Department Stores

Calendar

2024-08-11 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Internet & Mail Order Department Stores

	1st Jan change	Capi.
HLB GLOBAL CO., LTD.	-5.38%	163M
JD.COM, INC.	+2.47%	45.2B
COUPANG, INC.	+40.46%	40.66B
ALLEGRO.EU S.A.	+13.35%	10.11B
ETSY, INC.	-21.69%	7.42B
WAYFAIR INC.	-3.58%	7.25B
ZOZO, INC.	+15.84%	6.95B
FSN E-COMMERCE VENTURES LIMITED	-5.61%	5.62B
MONOTARO CO., LTD.	+7.70%	5.24B
OCADO GROUP PLC	-50.74%	3.9B